Fibrocell Science (FCSC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2004 | 06-2004 | 03-2004 | 12-2003 | 09-2003 | |
| Sales | 1,343 | 544 | 289 | 287 | 79 |
| Cost of Goods | 1,753 | 1,014 | 742 | 2,118 | 30 |
| Gross Profit | -410 | -470 | -453 | -1,831 | 48 |
| Operating Expenses | 6,980 | 3,425 | 5,174 | 2,237 | 2,797 |
| Operating Income | -6,637 | -3,881 | -4,885 | -3,950 | -2,718 |
| Other Income | 202 | 22 | 18 | 21 | 9 |
| Pre-tax Income | -6,435 | -3,859 | -4,867 | -3,929 | -2,709 |
| Net Income Continuous | -6,435 | -3,859 | -4,867 | -3,929 | -2,709 |
| Net Income | $-6,435 | $-3,859 | $-4,867 | $-3,929 | $-2,709 |
| EPS Basic Total Ops | -71.26 | -52.51 | -67.51 | -48.75 | -52.51 |
| EPS Basic Continuous Ops | -70.88 | -51.72 | -68.32 | -54.34 | -51.51 |
| EPS Diluted Total Ops | -71.26 | -52.51 | -67.51 | -48.75 | -52.51 |
| EPS Diluted Continuous Ops | -70.88 | -51.72 | -68.32 | -54.34 | -51.51 |
| EBITDA(a) | $-6,333 | $-3,608 | $-4,612 | $-3,745 | $-2,444 |